Upcoming Class Action Lawsuit for James Hardie Industries
NEW YORK -- Leading securities law firm Bleichmar Fonti & Auld LLP has announced a class action lawsuit against James Hardie Industries plc (NYSE: JHX) and its senior executives for securities fraud following a notable decrease in stock value. This situation emerged from potential violations of federal securities laws that prompted investors to raise concerns.
Investors Urged to Take Action
If you are someone who invested in James Hardie, it is essential to get further information. The firm encourages affected investors to connect and understand their rights and options moving forward. Investors must act before the approaching deadline to file their claims.
Filing Dates and Important Information
Those interested have until December 23 to request to lead the case in court. The allegations are based on claims as per Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, representing shareholders of James Hardie’s common stock. The case is currently under deliberation in the U.S. District Court for the Northern District of Illinois, centered around Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc.
What Led to the Lawsuit?
James Hardie holds a reputation for producing high-performance fiber cement building products, popularly utilized in external siding for the residential construction industry across various regions. During the pertinent period, the company represented its fiber cement segment results as indicative of inherent strength and momentum.
The Stock Decline and Its Implications
However, it was alleged that the company's North American sales were artificially inflated due to inventory loading by channel partners rather than genuine customer demand. The real situation became evident on August 19, when James Hardie disclosed a 12% decline in North American sales charge, attributed to a process of destocking initiated by customers aiming to return to normal inventory levels. Following this revelation, the stock price dropped significantly from $28.43 to $18.64 per share.
Management Changes and Continued Issues
Moreover, in a surprising turn of events and as further evidence of the company's volatility, CFO Rachel Wilson announced her departure from the firm on November 17. This transition may add another layer of uncertainty for investors as the company navigates through its current challenges.
Potential Next Steps for Investors
Investors should explore their legal options regarding this situation. If you've invested in James Hardie, the firm encourages you to submit your information to ensure your interests are represented. Through contingency fee arrangements, shareholders will not bear any court costs or litigation expenses. Legal fees will only be pursued upon court approval for fees and associated costs.
Contact Information
To learn more about your options, please contact Ross Shikowitz at 212.789.3619 or via email at ross@bfalaw.com. It’s crucial to act swiftly and ensure your representation in this legal matter.
Why Choose Bleichmar Fonti & Auld LLP?
BFA is recognized as a leading law firm specializing in securities class actions and shareholder litigation. Its commitment to representing plaintiffs has earned accolades from numerous legal organizations. Noteworthy recoveries include over $900 million from Tesla and $420 million from Teva Pharmaceutical Ind. Ltd. Understanding the robust record and experience of BFA could significantly benefit your case.
Frequently Asked Questions
What is the deadline to join the class action lawsuit?
The deadline to file to lead the case is December 23.
Who can file a claim?
Any investor who purchased common stock in James Hardie Industries during the specified period may file a claim.
What allegations are being made against James Hardie?
The firm is facing allegations of securities fraud and misrepresentation of sales figures.
What legal expenses will investors incur?
All representation is under a contingency fee basis, meaning no upfront costs for shareholders.
Who should I contact for more information?
Investors should reach out to Ross Shikowitz at 212.789.3619 or via email for personal assistance.
